Product Manual

3
Status Flu A
&
B
Nasopharyngeal Wash/Aspirate Sample Procedure
(Purchase of BSP-510AS required)
PROCEDURE
TEST DEVICE
Slowly
Tap
1
2
4
5
6
7
8
9
3
Extraction
Reagent
B
C
Influenza
Date______
ID________
A
B
C
Influenza
Date______
ID________
A
Influenza
Date
ID
C
B
A
Extraction Well
Result Window
Squeeze
here
Star t timing.
Sample
Slowly
Tap
2
3
6
7
8
9
B
A
C
Influenza
Date______
ID________
B
A
C
Influenza
Date______
ID________
4
B
A
C
Influenza
Date______
ID________
5
B
A
C
Influenza
Date______
ID________
PROCEDURE
TEST DEVICE
1
Influenza
Date
ID
C
B
A
Extraction Well
Result Window
Swab Stand
Star t timing.
Status Flu A
&
B
Swab Sample Procedure
Reproducibility
The reproducibility study for Status Flu A & B test was conducted at two
physicians’ offices and one laboratory using a panel of 90 coded specimens for
each site. Testing was performed by two personnel for five days at each site. The
panel consists of coded samples of high negative, low positive and moderate
positive specimens for each of influenza A and B. For influenza A and B positive
samples, A/PR/8/34 (H1N1) and B/Maryland/1/59 were used. The low positive
was the LOD level of each strain. Each specimen level was tested in triplicate
every day per operator. Each operator conducted the tests using the coded
samples following the test protocol given in the package insert as if they are
testing patient sample including the sample extraction step.
The results obtained at each site agreed 100% with the expected results. No
differences were observed within run (15 replicates), between runs (five different
days), or between sites (two POL sites and one lab).
Analytical Sensitivity
Limit of Detection (LOD)
The LODs were determined for each of the two strains selected from the
influenza type A and type B strains listed in the analytical inclusivity (sensitivity)
section below. The sensitivity level of each selected viral strain established in the
above study analytical inclusivity (sensitivity) study was tested 60 times to
confirm the sensitivity level as LOD level, which gives 95% detection rate.
All four viral strains tested were detected 96.7% of the time in 60 replicates.
6
Influenza
Type
#Positive/
#Total
% PositiveViral Strain TCID
50
/mL
A A/PR/8/34 (H1N1) 1.05 X 10
2
58/60 96.7
9.95 X 10
1
A A/Victoria/3/75 (H3N2) 58/60 96.7
1.58 X 10
3
B B/Taiwan/2/62 58/60 96.7
1.99 X 10
1
B B/Maryland/1/59 58/60 96.7
Influenza
Type
Viral Strain TCID
50
/mL
A A/PR/8/34 (H1N1) 1.05 X 10
2
1.73 X 10
1
A A/FM/1/47 (H1N1)
4.10 X 10
3
A A/NWS/33 (H1N1)
8.5 X 10
2
A A/Hong Kong/8/68 (H3N2)
7.20 X 10
0
A A/Denver/1/57 (H1N1)
9.95 X 10
0
A A/Aichi/2/68 (H3N2)
9.95 X 10
1
A A/Victoria/3/75 (H3N2)
1.99 X 10
2
A A/Port Chalmers/1/73
9.95 X 10
1
A A/New Jersey/8/76 (H1N1)
5.00 X 10
0
B B/Lee/40
1.58 X 10
0
B B/Allen/45
9.95 X 10
2
B B/GL/1739/54
1.58 X 10
3
B B/Taiwan/2/62
1.99 X 10
1
B B/Maryland/1/59
5.00 X 10
1
B B/Mass/3/66
2.94 X 10
3
B B/R75
1.6 X 10
-1
B B/R22 Barbara
3.16 X 10
3
B B/Russia/69
2.88 X 10
1
B B/Hong Kong/5/72
5.00 X 10
1
A
A/WS/33 (H1N1)
1.58 X 10
2
A
A/Swine/1976/31
6.15 X 10
3
A A/CA/07/2009 (H1N1)
9.31 X 10
3
A A/CA/08/2009 (H1N1)
8.51 X 10
3
A A/Mexico/4108/2009 (H1N1)
2.5 X 10
3
A A/NY/18/2009 (H1N1)
1.08 X 10
3
A A/CA/07/2009 NYC, X-179A (H1N1)
2.32 X 10
3
A
A/Virginia/ATCC2/2009 (H1N1)
5.00 X 10
4
A
A/Virginia/ATCC3/2009 (H1N1)
1.00 X 10
3
A
2009 H1N1 Clinical Isolate* (Swine Origin Influenza A)
Analytical Inclusivity
The analytical inclusivity (sensitivity) was established for a total of 29
influenza strains: 19 strains of influenza A type and 10 strains of influenza B
type. The results are shown in the table below.
*Clinical isolate cultured and tittered. Culture confirmed positive for 2009 H1N1
Influenza A strain using proFLU Influenza A Subtyping
Flu A
Positive
Status
Flu A & B
Flu A
Positive
Flu A
Negative
Total Agreement
Flu A
Negative
Total
50 0 50 100%
0 30 30 100%
50 30 80
Reference (Virus Culture) Results
Flu B
Positive
Status
Flu A & B
Flu B
Positive
Flu B
Negative
Total
Agreement
Flu B
Negative
Total
30 0 30
100%
0 50 50 100%
30 50 80
Reference (Virus Culture) Results
Flu A
Positive
Status
Flu A & B
Flu A
Positive
Flu A
Negative
Total Agreement
Flu A
Negative
Total
50 0 50 100%
0 30 30 100%
50 30 80
Reference (Virus Culture) Results
Flu B
Positive
Status
Flu A & B
Flu B
Positive
Flu B
Negative
Total Agreement
Flu B
Negative
Total
30 0 30 100%
0 50 50 100%
30 50 80
Reference (Virus Culture) Results
Swab Sample
As further verification of the PCR test results shown from the samples with
discrepant results between Status and viral culture, available archived remnant
samples from the clinical studies with concordant results were also tested by PCR.
The PCR was performed on 138 Flu A negative and 27 Flu A positive samples with
Status and culture, and 154 Flu B negative and 11 Flu B positive samples with
Status and Culture. The specificity for both Flu A and Flu B was 100%, while the
sensitivity for Flu A was 90% and the sensitivity for Flu B was 91.7%.
Archived Sample Test Results
Eighty (80) frozen archived samples originally obtained from influenza positive
patients visiting Columbia NY Presbyterian Hospital and confirmed as positive for
either influenza A or Influenza B by viral culture were tested with Status Flu A & B.
The tables below present test results with archived samples.
Aspirate Sample
Squeeze the Extraction Reagent
capsule to dispense all of the
solution into the Extraction Well
of the test device.
Place the specimen swab on
the Swab Stand in the
Extraction Well.
Incubate 1 minute
with the swab in
Extraction Well.
Tear the tab off the Extraction
Reagent Capsule.
Draw nasal wash or
nasopharyngeal aspirate sample
to the first (lowest) mark of the
graduated transfer pipette.
Dispense all of the solution
in the transfer pipette into
the Extraction Well of the
test device.
Incubate 1 minute.
Re-cap the Extraction
Reagent bottle.
Raise the test device
upright (see picture).
Let it stand for 1-2 seconds.
Tap the device on a flat surface
to ensure that the liquid flows
into the hole.
Read test results at 10-15
minutes.
Confirm negative results at 15
minutes.
Immediately after tapping,
slowly lay the device back
down onto the flat surface.
Dispense the entire
sample in the transfer
pipette into the
Extraction Well of the
test device.
Hold the device with
one hand and the
swab with the other.
While pressing down
on the swab, rotate it
completely in one
direction 3 times to
mix the specimen.
Hold the device with
one hand and the
swab with the other.
While pressing down
on the swab, rotate it
in one direction 3
times to mix the
specimen.
Remove and discard
the swab.
Raise the device upright
(see picture).
Let it stand for 1–2
seconds. Gently tap the
device on a flat surface to
ensure that the liquid
flows into the hole.
Immediately after tapping,
slowly lay the device back
down onto the flat surface.
Read test results at 10-15 minutes.
Confirm negative results at 15
minutes.
Using a new transfer
pipette, draw Extraction
Reagent Solution to the
first (lowest) mark.